Imprivata has introduced a new facial recognition solution that will make it easier (and safer) for doctors to prescribe controlled substances electronically. The Imprivata offering will specifically allow people to self-enroll in Electronic Prescriptions for Controlled Substances (EPCS) programs, instead of forcing them to go to a doctor’s office to register in person.
IDEMIA and Aware are acting as Imprivata’s technology partners for the project. The new platform identifies users with IDEMIA’s facial recognition tech, while Aware is providing liveness detection to prevent spoofing. Together, the two companies will allow people to bind their identity to their mobile device with a process that can be completed in as little as two minutes.
According to Imprivata, that represents a dramatic improvement on the current convention, which requires a live witness for device registration. The face-based solution is able to verify someone’s identity remotely, and ensures that the right person is in fact present for the interaction. As a result, it will help streamline healthcare workflows and support a more fully realized digital identity strategy that is still compliant with the DEA’s latest EPCS requirements.
“This mobile facial recognition solution eliminates the inconvenience of supervised enrollment of a new phone by allowing providers to self-enroll,” said Imprivata Chief Medical Officer Sean Kelly. “This is highly convenient for providers and minimizes disruption of their electronic prescribing ability, saving hours and even days compared to standard enrollment procedures.”
Imprivata is best known for its PatientSecure patient identification platform, which uses palm vein recognition to verify patient identities in a clinical setting. The company teamed up with Keyo to deliver a contactless version of the platform in October of 2020.
IDEMIA’s facial recognition algorithm posted the top score in the most recent round of the NIST’s 1:N Face Recognition Vendor Test. Meanwhile, Aware’s liveness tech has cleared Level 1 and Level 2 of iBeta’s Presentation Attack Detection evaluation.
May 26, 2021 – by Eric Weiss